Remote Jobs at Viking Therapeutics, Inc.
Viking Therapeutics, Inc.
51 - 200 employees
Founded 2012
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $500M Post-IPO Debt on 2026-09
Biotechnology • Pharmaceuticals
Viking Therapeutics, Inc. is a clinical-stage biotechnology company advancing next-generation therapies for obesity and metabolic and endocrine disorders. The company’s lead program, VK2735, is a dual GLP-1/GIP receptor agonist being developed as both oral and injectable formulations and is in Phase 3 obesity studies. Viking’s pipeline also includes programs targeting metabolic and liver diseases (e. g. , VK2809) and next-generation approaches such as amylin-based therapies. The company emphasizes treating obesity as a chronic disease to achieve long-term health benefits including improved cardiovascular health, physical function, and quality of life.
📡 We watch Viking Therapeutics, Inc.'s careers page
Several times a day
how often we check
4
roles posted in the last 30 days
Is on LinkedIn?
